109 related articles for article (PubMed ID: 7509513)
1. Correlation between platelet aggregation and dephosphorylation of a 68 kDa protein revealed through the use of putative PKC inhibitors.
Turini ME; Gaudette DC; Holub BJ; Kirkland JB
Thromb Haemost; 1993 Oct; 70(4):648-53. PubMed ID: 7509513
[TBL] [Abstract][Full Text] [Related]
2. The phospholipase C inhibitor U73122 inhibits phorbol ester-induced platelet activation.
Lockhart LK; McNicol A
J Pharmacol Exp Ther; 1999 May; 289(2):721-8. PubMed ID: 10215645
[TBL] [Abstract][Full Text] [Related]
3. KRDS, a peptide derived from human lactotransferrin, inhibits thrombin-induced thromboxane synthesis by a cyclooxygenase-independent mechanism.
Lévy-Toledano S; Grelac F; Caen JP; Maclouf J
Thromb Haemost; 1995 May; 73(5):857-61. PubMed ID: 7482416
[TBL] [Abstract][Full Text] [Related]
4. Role of protein kinase C in U46619-induced platelet shape change, aggregation and secretion.
Nakano T; Hanasaki K; Arita H
Thromb Res; 1989 Oct; 56(2):299-306. PubMed ID: 2617470
[TBL] [Abstract][Full Text] [Related]
5. Galpha12 and galpha13 are phosphorylated during platelet activation.
Offermanns S; Hu YH; Simon MI
J Biol Chem; 1996 Oct; 271(42):26044-8. PubMed ID: 8824244
[TBL] [Abstract][Full Text] [Related]
6. Phenol red is a thromboxane A2/prostaglandin H2 receptor antagonist in canine lingual arteries and human platelets.
Greenberg SS; Johns A; Kleha J; Xie J; Wang Y; Bianchi J; Conley K
J Pharmacol Exp Ther; 1994 Mar; 268(3):1352-61. PubMed ID: 8138950
[TBL] [Abstract][Full Text] [Related]
7. Combined administration of 5-HT2 and thromboxane A2 antagonists: effects on platelet aggregation and isolated cardiac muscle.
Shaw LA; Batey AJ; Coker SJ
Br J Pharmacol; 1997 Jul; 121(5):875-82. PubMed ID: 9222543
[TBL] [Abstract][Full Text] [Related]
8. The fibrinogen-derived peptide (RGDS) prevents proteolytic degradation of protein kinase C in platelets by inhibiting platelet aggregation.
Krishnamurthi S; Dickens TA; Patel Y; Wheeler-Jones CP; Kakkar VV
Biochem Biophys Res Commun; 1989 Sep; 163(3):1256-64. PubMed ID: 2783136
[TBL] [Abstract][Full Text] [Related]
9. Cordycepin (3'-deoxyadenosine) inhibits human platelet aggregation induced by U46619, a TXA2 analogue.
Cho HJ; Cho JY; Rhee MH; Lim CR; Park HJ
J Pharm Pharmacol; 2006 Dec; 58(12):1677-82. PubMed ID: 17331333
[TBL] [Abstract][Full Text] [Related]
10. Thromboxane synthase inhibitors suppress more effectively the aggregation of thromboxane receptor-desensitized than that of normal platelets: role of adenylylcyclase up-regulation.
Vezza R; Nenci GG; Gresele P
J Pharmacol Exp Ther; 1995 Dec; 275(3):1497-505. PubMed ID: 8531121
[TBL] [Abstract][Full Text] [Related]
11. Role for p38 mitogen-activated protein kinase in platelet aggregation caused by collagen or a thromboxane analogue.
Saklatvala J; Rawlinson L; Waller RJ; Sarsfield S; Lee JC; Morton LF; Barnes MJ; Farndale RW
J Biol Chem; 1996 Mar; 271(12):6586-9. PubMed ID: 8636072
[TBL] [Abstract][Full Text] [Related]
12. Tyrosine phosphorylation of pp125FAK in platelets requires coordinated signaling through integrin and agonist receptors.
Shattil SJ; Haimovich B; Cunningham M; Lipfert L; Parsons JT; Ginsberg MH; Brugge JS
J Biol Chem; 1994 May; 269(20):14738-45. PubMed ID: 7514181
[TBL] [Abstract][Full Text] [Related]
13. Antiaggregatory activity of 8-epi-prostaglandin F2 alpha and other F-series prostanoids and their binding to thromboxane A2/prostaglandin H2 receptors in human platelets.
Yin K; Halushka PV; Yan YT; Wong PY
J Pharmacol Exp Ther; 1994 Sep; 270(3):1192-6. PubMed ID: 7932171
[TBL] [Abstract][Full Text] [Related]
14. Interaction of nitric oxide and cGMP with signal transduction in activated platelets.
Nguyen BL; Saitoh M; Ware JA
Am J Physiol; 1991 Oct; 261(4 Pt 2):H1043-52. PubMed ID: 1656783
[TBL] [Abstract][Full Text] [Related]
15. Desensitization of platelet thromboxane A2/prostaglandin H2 receptors by the mimetic U46619.
Liel N; Mais DE; Halushka PV
J Pharmacol Exp Ther; 1988 Dec; 247(3):1133-8. PubMed ID: 2974487
[TBL] [Abstract][Full Text] [Related]
16. Inhibitory effects of resveratrol on platelet activation induced by thromboxane a(2) receptor agonist in human platelets.
Yang Y; Wang X; Zhang L; An H; Zao Z
Am J Chin Med; 2011; 39(1):145-59. PubMed ID: 21213405
[TBL] [Abstract][Full Text] [Related]
17. A novel inhibitor of platelet aggregation from the Cyanophyceae Oscillatoria rosea (NIES-208).
Rho MC; Matsunaga K; Yasuda K; Ohizumi Y
Planta Med; 1996 Oct; 62(5):473-4. PubMed ID: 8923815
[TBL] [Abstract][Full Text] [Related]
18. Thromboxane-insensitive dog platelets have impaired activation of phospholipase C due to receptor-linked G protein dysfunction.
Johnson GJ; Leis LA; Dunlop PC
J Clin Invest; 1993 Nov; 92(5):2469-79. PubMed ID: 8227362
[TBL] [Abstract][Full Text] [Related]
19. A possible role for extracellular bicarbonate in U-46619-induced rat platelet aggregation.
Yokoyama K; Kudo I; Nakamura H; Inoue K
Thromb Res; 1994 May; 74(4):369-76. PubMed ID: 8085238
[TBL] [Abstract][Full Text] [Related]
20. Calpain-induced down-regulation of protein kinase C inhibits dense-granule secretion in human platelets. Inhibition of platelet aggregation or calpain activity preserves protein kinase C and restores full secretion.
Patel Y; Kakkar VV; Authi KS
Biochim Biophys Acta; 1994 Dec; 1224(3):480-8. PubMed ID: 7803507
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
